Research Reveals Early Stages of Multiple Sclerosis
Summary: A team of researchers has discovered that multiple sclerosis (MS) can start affecting the immune system as early as seven years prior to an official diagnosis. They examined over 5,000 blood proteins and found early indicators of myelin damage, which is the protective layer surrounding nerve fibers, occurring well before any noticeable symptoms arise.
Important biomarkers like IL-3 and MOG suggest a two-phase attack, initially focusing on the myelin and, later on, the nerve fibers themselves. This finding could lead to the development of an early blood test for diagnosis and potential preventive treatments for MS.
Key Facts:
- Early Detection: Evidence of myelin damage appears up to seven years before an MS diagnosis, marked by an increase in the MOG protein.
- Markers of Immune Activity: IL-3 is crucial in gathering immune cells that instigate early brain inflammation.
- New Diagnostic Possibilities: Researchers pinpointed 21 proteins that may be used in a predictive blood test for MS.
Research Overview:
Patients often don’t realize their multiple sclerosis (MS) is causing brain damage until long after the initial assaults have begun. Until recently, the specific timing and targets of these attacks were unclear.
However, researchers at UC San Francisco have now illuminated the early stages of myelin sheath damage, indicating that the immune system starts its assault earlier than previously understood.
The study involved analyzing blood samples to measure signs of these attacks, revealing the timeline of events leading to MS. This work could enable earlier diagnosis and possibly prevention of the disease.
It appears that MS first damages the fatty myelin sheath, and approximately a year later, symptoms linked to nerve fiber deterioration become evident.
Among various immune signaling proteins, IL-3 stood out as its level increased significantly early on. It is known for recruiting immune cells into the brain and spinal cord, leading to nerve cell attacks, often before a person feels any effects.
“Our findings may open new roads for diagnosing, monitoring, and even treating MS,” noted Dr. Ahmed Abdelhak from UCSF. “It could change how we perceive and address this condition.”
Researchers studied over 5,000 proteins in blood from 134 MS patients, both prior to and following their diagnosis. These samples came from the U.S. Department of Defense Serum Repository, providing a unique resource that could trace back many years.
Seven years before a diagnosis, an increase in a protein named MOG was noted, indicating early myelin damage. A year later, a rise in neurofilament light chain suggested injury to the nerve fibers themselves.
During this period, both IL-3 and other related proteins indicated an impending immune reaction.
In total, about 50 proteins were flagged as precursors to disease, with a patent application submitted for a blood test based on the 21 most relevant proteins.
Dr. Ari Green, a senior author of the study, expressed optimism for future prevention efforts and enhanced understanding of MS symptom development. “We recognize now that MS initiates well before any clinical signs, indicating a possible path toward prevention or at least safeguarding against further damage.”
Key Questions Answered:
A: The study found immune attacks commence on the myelin sheath up to seven years before symptoms show or patients seek help.
A: By examining blood samples from military personnel collected years before any MS diagnosis, researchers noted specific protein increases signaling nerve and brain damage.
A: These discoveries could transform early diagnostic techniques and preventive measures for MS, potentially allowing for intervention before severe nerve damage occurs.
About this Multiple Sclerosis and Neurology Research
Funding: This research received funding from various organizations, including the Department of Defense and the National Institutes of Health, among others.
